Executive Director, Cancer Vaccine Neoantigen Engineering, Early Infectious Disease
About this opportunity
The Executive Director of Cancer Vaccine Neoantigen Engineering will lead the molecular engineering and construction of a portfolio of cancer vaccines designed to generate broad, potent, and durable anti-tumor cellular immunity. The role will identify, prioritize, and engineer diverse tumor antigen classes and translate them into precision multi-antigen/epitope constructs optimized for T-cell breadth, clonal expansion, functional potency, and long-term immune surveillance.
The Executive Director will build deep capabilities to master the rules governing antigen processing, pMHC presentation, and TCR recognition, integrating genomic, transcriptomic, immunopeptidomic, structural, and TCR repertoire data to understand what makes an antigen naturally presented, immunologically visible, and capable of driving functional tumor-cell killing. These insights will establish predictive design principles for epitope selection and immunogen engineering. A major focus will be developing innovative antigen-cassette architectures that robustly induce cellular immunity. Designs will seek to balance immunodominance, coordinate CD8⁺ cytotoxicity with CD4⁺ T-cell help, minimize antigen escape, and maximize the magnitude, breadth, polyfunctionality, cytotoxicity and persistence of vaccine-induced T-cell responses.
The Executive Director will establish an integrated antigen-engineering engine connecting computational design with experimental validation and iterative optimization. Working across immunology, oncology, computational sciences, protein engineering, and translational sciences, the role will build differentiated capabilities and intellectual property in engineered immunogens, multi-antigen cassette architectures, immune-routing strategies, and sequence-design algorithms, creating a scalable platform for the predictive design of best-in-class cancer vaccines.
Accountabilities:
Establish a best-in-class epitope discovery, validation, and engineering pipeline
Optimize epitope sequence design and create a multi-antigen architectural design tool
Engineer antigen expression constructs that maximize T cell breadth, clonal expansion, and durability
Create differentiated intellectual property around epitope design and antigen construct architecture
Work with cross-disciplinary teams to guide iterative antigen design and preclinical evaluation
Establish strategic relationships across the organization and functions
Build group and expertise around the design of vaccine candidates taking into account target antigens and target indications
Create and foster effective relationships with senior and executive stakeholders in Research, Bioprocess Development, Clinical and Translational Medicine and Global Project Teams to ensure alignment across functions
Pioneer AI based strategies to accelerate the pace of innovation at all levels of research
Collaborate and guide the evaluation of novel business development opportunities
Communicate results internally and externally, as well as their associated risks, uncertainties and limitations
Define the training standards for junior colleagues in line with best practices and principles
Essentials
PhD or equivalent in bioinformatics, immunology, oncology, molecular biology, biochemistry or a related discipline with 10+ yrs industry experience
Proven experience developing vaccines to target different antigens in a variety of disease settings
Proven experience with generating multiple vaccine constructs and testing constructs to identify optimal design of vaccine candidates
Experience working in a cross-functional team to maximize expertise and accelerate success
Experience developing and implementing novel methods to support vaccine development
Experience supporting or leading interdisciplinary vaccine discovery or development programs
Proven experience leading and managing junior colleagues
Proven experience developing and controlling budgets
Excellent written and verbal communication, business analysis, and consultancy skills
Annual base salary for this position ranges from $ 281,872.80 - $422,809.20. AstraZeneca is committed to providing fair and equitable compensation opportunities to all colleagues. Our compensation policies and practices have been designed to allow colleagues to progress through the salary range over time as they progress in their role. The range provided in this posting represents an offer pay range used in a majority of situations. The base pay offered will vary depending on multiple individualized factors, including the candidate's skills and experience, job-related knowledge, and other specific business and organizational needs. In some cases, offers outside the range may also be considered to address unique circumstances.
In addition, our permanent positions offer an annual Variable Pay Bonus/Short Term Incentive opportunity as well as eligibility to participate in our equity-based long-term incentive program (if applicable to role). Benefits offered for permanent roles include a competitive Flex Benefits & Retirement Savings Program, 4 weeks’ paid vacation, and annual Personal Days. Fixed Term Contract/Temporary positions (excluding students) are offered a Contract Benefits Program.
We are using AI as part of the recruitment process.
Date Posted
10-Nov-2026
Closing Date
23-Nov-2026 Our mission is to build an inclusive environment where equal employment opportunities are available to all applicants and employees. In furtherance of that mission, we welcome and consider applications from all qualified candidates, regardless of their protected characteristics. If you have a disability or special need that requires accommodation, please complete the corresponding section in the application form.
Job details
How this role compares
Computed from every other active Drug Discovery & Preclinical Research role in our database, not just this employer's listings.
We currently track 37 comparable Executive/VP Drug Discovery & Preclinical Research roles across 19 biopharma companies.
Salary context
24 of 37 peers report a salary range (USD, annualized)
Peers share this role's job function and a matching or adjacent seniority level -- not necessarily the same therapeutic area or country.
Where these roles are based
Top locations among the 37 comparable roles
Seniority mix
37 of 37 peers have a known seniority level
Therapeutic area mix
18 of 37 peers have a known therapeutic area; the rest are genuinely unlabeled, not hidden
Similar opportunities
The closest matches from our peer group, ranked by how similar they are, not how well you'd qualify for them -- treat this as market context, not a guaranteed shortlist; a weak match is labeled as one below.
Open in 2 locations
Notify me about similar jobs
Get an email when we spot other openings like this one – same job function, comparable seniority, roles you'd actually want to see.
Or follow a whole field: get every new Drug Discovery & Preclinical Research job in the United States, and choose locations and companies.
How we calculate "similar"
No black box, no LLM guesswork: a deterministic score built from four normalized attributes. Here's this role's own peer group at different match levels, so you can see the mechanism, not just the result.
Every comparison starts from the same 100-point budget: 25 for working in the same function, 40 for the same therapeutic area, 20 for the same or adjacent seniority, 15 for the same country. A dimension we can't confirm on both sides contributes nothing, never a guess, never a free pass.
0 points, never a partial guess. A role we know almost nothing about beyond its function bottoms out at 25%; it never inflates to 100% just because there's little to compare against. Seniority uses a defined ladder (Associate → Manager → Associate Director → Senior → Principal → Director → Senior Director → Executive/VP) so "Director" and "Senior Director" count as adjacent, but "Director" and "Executive/VP" do not.